Nanomedicine in Cancer Immunotherapy

Häftad, Engelska, 2024

2 360 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Nanomedicine in Cancer Immunotherapy bridges the two disciplines of nanotechnology and immunology, summarizing the latest research into novel cancer treatments, often personalized to the patient. The book covers a wide range of nanomaterial types for use in cancer immunotherapy, including hydrogel, lipid, exosome, gold and peptide nanoparticles. The preparation, application, pros and cons of each nanomaterial class is reviewed, helping the reader understand the potential for each to tailor their own selections. Nanovaccines are also covered, along with a clinical evaluation and market analysis of nanomedicines for immunotherapy, offering an important clinical and commercial overview of this rapidly developing field.

This book is an interesting reference for those working in the fields of nanotechnology, immunology, and cancer therapeutics, as well as clinicians with an interest in novel nano-based cancer treatments.

Provides a single source for a review of the latest research in the development of nanomaterials for cancer immunotherapy
Introduces the reader to basic principles of immunology and immunotherapy to aid our understanding
Details a wide range of nanomaterial classes for cancer immunotherapy, with advantages and disadvantages thoroughly analyzed

Produktinformation

Utgivningsdatum:2024-01-16
Mått:152 x 229 x 28 mm
Vikt:1 000 g
Format:Häftad
Språk:Engelska
Antal sidor:500
Förlag:Elsevier Science
ISBN:9780443187704

Utforska kategorier

Onkologi inom Medicin
Biokemisk teknik inom Naturvetenskap och teknik
Biomedicinsk teknik inom Medicin

Mer om författaren

Dr. Prashant Kesharwani is assistant professor of Pharmaceutics at Department of Pharmaceutical Sciences, Dr. Harisingh Gour Vishwavidyalaya University, Sagar, Madhya Pradesh, India. He has more than 12 years of teaching, research, and industrial experience across various countries. An overarching goal of his current research is the development of nanoengineered drug delivery systems for various diseases. He has published many articles in well-reputed journals and a large number of books. He is a recipient of many research grants from various funding bodies. He is also the recipient of several internationally acclaimed awards, such as “USERN Laureate award, and “SERB-Ramanujan Fellowship Award. He has presented many invited talks and oral presentations at prestigious scientific peer-conferences, received international acclaims and awards for research contribution, supervised students/junior researchers and actively participated in outreach and scientific dissemination for the service of the wider community.

Innehållsförteckning

1. Immunoadjuvants for cancer immunotherapy2. Nanotechnology as an emerging option in cancer immunotherapy3. Different administration routes for nanovectors in cancer immunotherapy4. Two-dimensional materialbased nanomedicines for cancer immunotherapy5. Hydrogel-based nanomedicines for cancer immunotherapy6. Exosomes-based nanomedicines for cancer immunotherapy7. Lipid-based nanomedicines for cancer immunotherapy8. Inorganic nanoparticle-based nanomedicines for cancer immunotherapy9. Liposome-based nanomedicines for cancer immunotherapy10. Biomembrane-based nanoparticles for cancer immunotherapy11. Dendrimer-based nanomedicines for cancer immunotherapy12. Magnetic nanocarriers for cancer immunotherapy13. Inhaled delivery of immunotherapy for treatment of lung cancer14. Nano-based vaccination and their administration routes in cancer immunotherapy15. Current status, challenges, and future perspective of nanomedicine-based cancer immunotherapy